Asset

Erythromycin

Biofrontera Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 050769NDABIOFRONTERA INC

Marketed products (1)

  • AKTIPAK